跳至主要内容
临床试验/NCT00512031
NCT00512031终止不适用

Characterizing the Effects of PAI-1 Modulation on Human Monocyte Function - The Effect of PAI-1 Post-transcriptional Regulation on Human Monocyte Adhesion

Vanderbilt University1 个研究点 分布在 1 个国家实际入组 50 人开始时间: 2007年1月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
50
试验地点
1

研究概览

简要总结

To determine how altering the expression of a gene known as PAI-1 may affect the adhesive capacity of cells that play a critical role in the developement of human atherosclerosis.

详细描述

The principal aim of this study is to determine if molecular regulation of the human gene PAI-1 alters the migratory properties of human myeloid and endothelial cells sufficiently enough to regulate entry and exit from the vascular space. Human monocyte become the key cellular orchestrators of human atherosclerotic plaque. We believe that a "loss" of PAI-1 activity may promote a pro-atherogenic effect in human vasculature thereby defining a novel atheroprotective effect for PAI-1 when expressed at normal levels in humans. By using RNA interference to achieve PAI-1 gene, we hope to elucidate the mechanistic basis of how PAI-1 regulation may affect human migration within the vasculature.

研究设计

研究类型
观察性
观察模型
队列研究
时间视角
前瞻性

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • Ages 18-50
  • No current or past medical problems

排除标准

  • Patients taking prescription drugs (hormonal birth control or herbal supplements may be taken)

研究者

申办方类型
其他

研究点 (1)

Loading locations...

标识符

NCT 编号
NCT00512031
其他研究编号
070079

日期

首次提交
(19年前)
首次发布
(19年前)
主要完成日期
研究完成日期
最近核实
最近更新
(15年前)

监管与共享

FDA 监管药物
否
是否有结果
否

相似试验